Search

Seattle Biotech Blaze Bioscience Adds $16M for Clinical Trial Work

SEATTLE BIOTECH BLAZE BIOSCIENCE ADDS $16M FOR CLINICAL TRIAL WORK

Blaze Bioscience, a Seattle-based biotech that's developing “tumor paint” to help surgeons differentiate healthy tissue from tumors...

 
 
 

ADMINISTRATIVE ASSISTANT - ONCOLOGY - CARLSBAD, CA

Requires the ability to quickly pick up on various IT systems to support data exports and various reporting tools...From Oncology -...

Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More

BIO ROUNDUP: NOBEL PURSUIT, FUNDRAISING FRUIT, A RHYTHMIC IPO & MORE

The 2017 Nobel Prizes with a biomedical bent were announced this week. Three researchers shared the physiology and medicine prize for...

 
 
 
 
 
 
Pete's Bluebird Provides Ongoing and Heartfelt Support

PETE'S BLUEBIRD PROVIDES ONGOING AND HEARTFELT SUPPORT

In memory of their best friend Katie For siblings Bill Coniaris and Eleni “Stammy” Coniaris, Cummings School of Veterinary Medicine...

CULLINAN ONCOLOGY EMERGES WITH $150 MILLION AND A ROSTER OF ALL-STAR BIOTECH SCIENTISTS

Life Sciences Jobs ...

 
 
 
Cullinan Oncology Emerges with $150M to Build Cancer Drug Portfolio

CULLINAN ONCOLOGY EMERGES WITH $150M TO BUILD CANCER DRUG PORTFOLIO

It's no secret that discovering and developing cancer drugs is an expensive and risky endeavor. But Cullinan Oncology is betting that...

CULLINAN BAGS $150M TO BUILD BROAD SLATE OF CANCER ASSETS

Cullinan Oncology has raised $150 million to build a portfolio of cancer R&D programs. The idea is to manage the risks inherent in...

 
 
 
Endocyte Adds Phase 3-Ready Prostate Cancer Drug with ABX Deal

ENDOCYTE ADDS PHASE 3-READY PROSTATE CANCER DRUG WITH ABX DEAL

Four months after two Endocyte drug candidates stumbled in early-stage studies, sparking a corporate shakeup, the company has signed...

“Five Questions For. ” Austin Biotech Entrepreneur Paul Lammers

“FIVE QUESTIONS FOR. ” AUSTIN BIOTECH ENTREPRENEUR PAUL LAMMERS

Austin -Two years ago, Paul Lammers was riding the cancer immunotherapy wave in biotech. His firm, Mirna Therapeutics, hit the Nasdaq...

 
 
 
Amid Cash Crunch, Genocea to Dump Herpes Vaccine, Focus on Cancer Work

AMID CASH CRUNCH, GENOCEA TO DUMP HERPES VACCINE, FOCUS ON CANCER WORK

Genocea Biosciences was able to go from startup to publicly traded company, in part, because of the early progress it made developing...

 
 
 

QUALITY & DATA ANALYST RN - ONCOLOGY

IL-Springfield,

Moderna Ends “Venture” Experiment, Dissolves Four Startups

MODERNA ENDS “VENTURE” EXPERIMENT, DISSOLVES FOUR STARTUPS

Moderna Therapeutics, the high-flying private company with a $1 billion war chest, is reversing course. Three years ago, it decided...

 
 
 
Stop prostate cancer dead in its tracks by eating apples and grapes, reveals new research

STOP PROSTATE CANCER DEAD IN ITS TRACKS BY EATING APPLES AND GRAPES, REVEALS NEW RESEARCH

Eating apples and grapes may help stave off prostate cancer onset, the most common cancer among American men. As reported by Nature.com,...

Immunotherapy Safety Worries Halt Celgene Myeloma Study, Slow 5 Others

IMMUNOTHERAPY SAFETY WORRIES HALT CELGENE MYELOMA STUDY, SLOW 5 OTHERS

Amid growing concerns about the safety of a new class of cancer immunotherapy drugs when combined with other therapies to treat blood...

 
 
 
Notable Labs raises $10M for drug testing service to develop therapeutic index for oncologists

NOTABLE LABS RAISES $10M FOR DRUG TESTING SERVICE TO DEVELOP THERAPEUTIC INDEX FOR ONCOLOGISTS

The goal of the business is to help physicians identify the most suitable combinations of FDA-approved treatments that can be immediately...

Presage Bio Licenses Anti-Cancer Drug to San Diego's MEI Pharma

PRESAGE BIO LICENSES ANTI-CANCER DRUG TO SAN DIEGO'S MEI PHARMA

San Diego's MEI Pharma has agreed to pay $2.9 million upfront to Seattle-based Presage Biosciences for exclusive worldwide rights for...